CapBio has developed technologies to simplify diabetes management and improve the quality of life for millions of diabetics. The Company’s first product is a patented Continuous Subcutaneous Insulin Infusion (CSII) set and patent pending insertion device that improve the effectiveness of insulin delivery and double the duration of use.
